Evommune to Present at Upcoming Investor Conferences
Evommune (NYSE: EVMN) announced management presentations at upcoming investor conferences, beginning with Stifel Healthcare in New York on November 11, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
- Stifel Healthcare Conference 2026 in
New York : Fireside Chat on Wednesday, November 11, 2026, at 4:40 p.m. ET. - 2026 Jefferies Global Healthcare Conference in
London : Presentation on Wednesday, November 18, 2026, at 6:00 a.m. ET (11:00 a.m. GMT) - 9th Annual Evercore Healthcare Conference in
Coral Gables, FL : Fireside Chat on Wednesday, December 2, 2026, at 10:25 a.m. ET.
All webcasted presentations will be available on the News & Events section of the Company’s website at www.evommune.com. Archived replays will be available for 30 days.
About Evommune, Inc.
Evommune, Inc. is a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases. The Company’s mission is to improve patients’ daily lives and prevent the long-term effects of uncontrolled inflammation that result from the limitations of existing therapies. For more information, please visit www.evommune.com and follow us on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261109295795/en/
Media and Investors:
Megan Humphreys
megan.humphreys@evommune.com
Source: Evommune, Inc.